Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2009-08-11 | Mr. Winzer received his B.A. in Economics and Business Administration from McDaniel College and an M.B.A. from Mount Saint Mary’s University. |
| 2010-05-27 | C. Eric Winzer |
| 2010-08-25 | Mr. Winzer brings his experience and expertise in the areas of financial management and analysis, corporate governance, mergers and acquisitions to the Board and the Company. |
| 2011-08-22 | Mr. Winzer brings his experience and expertise in the areas of financial management and analysis, corporate governance, mergers and acquisitions to the Board and the Company. |
| 2012-04-16 | C. Eric Winzer - Independent director of the Company. Includes 136,667 shares Mr. Winzer may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan. |
| 2012-08-20 | Mr. Winzer currently serves as Chief Financial Officer of OpGen, Inc., a whole-genome analysis company. He has held several financial positions including CFO roles. |
| 2013-04-26 | C. Eric Winzer - Independent director of the Company. Includes 176,667 shares Mr. Winzer may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan. |
| 2013-11-12 | C. Eric Winzer has served as Director since January 30, 2009. Mr. Winzer currently serves as Chief Financial Officer of OpGen, Inc... Mr. Winzer received his B.A. in Economics and Business Administration from McDaniel College and an M.B.A. from Mount Saint Mary’s University. |
| 2014-05-02 | C. Eric Winzer - Independent director of the Company. Includes 216,665 shares Mr. Winzer may acquire upon the exercise of stock options approved by the Board and issued under the Companys 2002 Long-Term Incentive Plan and 2013 Equity Incentive Plan. |
| 2014-10-01 | Mr. Winzer received his B.A. in Economics and Business Administration from McDaniel College and an M.B.A. from Mount Saint Mary’s University. His expertise is in financial management and analysis. |
| 2017-04-28 | C. Eric Winzer - Independent director of the Company. Includes stock options granted under the Omnibus Plan. |
| 2018-08-28 | C. Eric Winzer - Independent director of the Company. |
| 2022-10-20 | Mr. Winzer has over 30 years of experience in addressing diverse financial issues including raising capital, financial reporting, investor relations, banking, taxation, mergers and acquisitions, financial planning and analysis, and accounting operations. Mr. Winzer has been the Chief Financial Officer at Immunomic Therapeutics, Inc., a privately-held clinical stage biotechnology company, since May 2015. From June 2009 to April 2015 Mr. Winzer served as the Principal Accounting Officer, Senior Vice President of Finance, and Chief Financial Officer for OpGen Inc. (OPGN), a precision medicine company that went public in May 2015. |
Data sourced from SEC filings. Last updated: 2026-02-03